|
MIRM
|
Mirum Pharmaceuticals, Inc.
|
0.35%
|
US
|
NASDAQ
|
|
ADMA
|
ADMA Biologics Inc
|
0.34%
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
0.32%
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.30%
|
US
|
NASDAQ
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
0.29%
|
US
|
NASDAQ
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
0.28%
|
US
|
NASDAQ
|
|
MRSN
|
Mersana Therapeutics, Inc.
|
0.28%
|
US
|
NASDAQ
|
|
ALLK
|
Allakos Inc.
|
0.28%
|
US
|
NASDAQ
|
|
KZR
|
Kezar Life Sciences, Inc.
|
0.28%
|
US
|
NASDAQ
|
|
REPL
|
Replimune Group, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
0.22%
|
US
|
NASDAQ
|
|
ITOS
|
iTeos Therapeutics, Inc.
|
0.22%
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
0.22%
|
US
|
NASDAQ
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
0.22%
|
US
|
NASDAQ
|
|
EGRX
|
Eagle Pharmaceuticals, Inc.
|
0.21%
|
US
|
NASDAQ
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.21%
|
US
|
NASDAQ
|
|
MCRB
|
Seres Therapeutics, Inc.
|
0.20%
|
US
|
NASDAQ
|
|
ALEC
|
Alector, Inc.
|
0.20%
|
US
|
NASDAQ
|
|
ANAB
|
AnaptysBio, Inc.
|
0.19%
|
US
|
NASDAQ
|
|
ACET
|
Adicet Bio, Inc.
|
0.18%
|
US
|
NASDAQ
|